Skip to Menu Skip to Search Contact Us Global Websites & Languages Skip to Content

About

This webinar will review the evolution of biosimilar regulations and their impact in the EU, US, and the rest of the world and discuss appropriate strategies for primary and higher order structure determination to demonstrate biosimilarity.

Starts

October 9, 2013, 10:00

Ends

October 9, 2013, 11:00

Location

Online

2013 is a landmark year for biosimilars, with the approval of the first biosimilar mAb and regulatory developments across the globe. Correctly interpreting the analytical requirements in these regulations is critical to demonstrate Biosimilarity.

This webinar will review the evolution of biosimilar regulations and their impact in the EU, US, and the rest of the world. Additionally, appropriate strategies for primary and higher order structure determination to demonstrate biosimilarity will be discussed, particularly for antibodies where their size and complexity requires LC/MS/MS approaches.

Date: October 9, 2013
Time: 10am EST; 4pm CET
Duration: 60 Minutes

For more information on this webinar and to register, please visit the registration page here.